“QIAGEN” therascreen EGFR RGQ PCR kit - Taiwan Registration fd3d10c7840d4f1d0530ee88373e2016
Access comprehensive regulatory information for “QIAGEN” therascreen EGFR RGQ PCR kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number fd3d10c7840d4f1d0530ee88373e2016 and manufactured by QIAGEN GMBH. The authorized representative in Taiwan is QIAGEN TAIWAN COMPANY LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
fd3d10c7840d4f1d0530ee88373e2016
Ministry of Health Medical Device Import No. 030485
DHA05603048508
Product Details
This product can detect 29 somatic mutations in EGFR gene in vitro, and can qualitatively evaluate the mutation status of tumor samples from patients with non-small cell lung cancer (NSCLC). The results of the assessment can be used to help clinicians identify patients with NSCLC who may benefit from EGFR tyrosine kinase inhibitor therapy.
B Hematology and pathology devices
B4020 Analyze specific reagents
Imported from abroad
Dates and Status
Jan 19, 2018
Jan 19, 2028